Which technique for radiation is most beneficial for patients with locally advanced cervical cancer? Intensity modulated proton therapy versus intensity modulated photon treatment, helical tomotherapy and volumetric arc therapy for primary radiation - an intraindividual comparison

被引:50
作者
Marnitz, Simone [1 ]
Wlodarczyk, Waldemar [1 ]
Neumann, Oliver [1 ]
Koehler, Christhardt [2 ]
Weihrauch, Mirko [1 ]
Budach, Volker [1 ]
Cozzi, Luca [3 ]
机构
[1] Charite, Dept Radiat Oncol, Berlin, Germany
[2] Charite, Dept Gynecol, Berlin, Germany
[3] Ist Clin Humanitas Canc Ctr & Reaserch Hosp, Radiosurg & Radiotherapy Dept, I-20100 Rozzano, Italy
关键词
Cervical cancer; Intensity-modulated radiotherapy; VMAT; Proton therapy; EXTENDED-FIELD IRRADIATION; PARAAORTIC LYMPH-NODES; CLINICAL TARGET VOLUME; CONCURRENT CHEMOTHERAPY; CISPLATIN CHEMOTHERAPY; PELVIC RADIOTHERAPY; HIGH-RISK; CARCINOMA; BRACHYTHERAPY; CHEMORADIOTHERAPY;
D O I
10.1186/s13014-015-0402-z
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: To compare highly sophisticated intensity-modulated radiotherapy (IMRT) delivered by either helical tomotherapy (HT), RapidArc (RA), IMRT with protons (IMPT) in patients with locally advanced cervical cancer. Methods and materials: Twenty cervical cancer patients were irradiated using either conventional IMRT, VMAT or HT; ten received pelvic (PEL) and ten extended field irradiation (EFRT). The dose to the planning-target volume A (PTV_A: cervix, uterus, pelvic +/- para-aortic lymph nodes) was 1.8/50.4 Gy. The SIB dose for the parametrium (PTV_B), was 2.12/59.36 Gy. MRI-guided brachytherapy was administered with 5 fractions up to 25 Gy. For EBRT, the lower target constraints were 95% of the prescribed dose in 95% of the target volume. The irradiated small bowel (SB) volumes were kept as low as possible. For every patient, target parameters as well as doses to the organs at risk (SB, bladder, rectum) were evaluated intra-individually for IMRT, HT, VMAT and IMPT. Results: All techniques provided excellent target volume coverage, homogeneity, conformity. With IMPT, there was a significant reduction of the mean dose (Dmean) of the SB from 30.2 +/- 4.0 Gy (IMRT); 27.6 +/- 5.6 Gy (HT); 34.1 +/- 7.0 (RA) to 18.6 +/- 5.9 Gy (IMPT) for pelvic radiation and 26.3 +/- 3.2 Gy (IMRT); 24.0 +/- 4.1 (HT); 25.3 +/- 3.7 (RA) to 13.8 +/- 2.8 Gy (IMPT) for patients with EFRT, which corresponds to a reduction of 38-52% for the Dmean (SB). Futhermore, the low dose bath (V-10Gy) to the small bowel was reduced by 50% with IMPT in comparison to all photon techniques. Furthermore, Dmean to the bladder and rectum was decresed by 7-9 Gy with IMPT in patents with pelvic radiation and EFRT. Conclusion: All modern techniques (were proved to be dosimetrically adequate regarding coverage, conformity and homogeneity of the target. Protons offered the best sparing of small bowel and rectum and therefore could contribute to a significant reduction of acute and late toxicity in cervical cancer treatment.
引用
收藏
页数:9
相关论文
共 33 条
[1]   Verification of patient-specific dose distributions in proton therapy using a commercial two-dimensional ion chamber array [J].
Arjomandy, Bijan ;
Sahoo, Narayan ;
Ciangaru, George ;
Zhu, Ronald ;
Song, Xiaofei ;
Gillin, Michael .
MEDICAL PHYSICS, 2010, 37 (11) :5831-5837
[2]   Early clinical outcome with concurrent chemotherapy and extended-field, intensity-modulated radiotherapy for cervical cancer [J].
Beriwal, Sushil ;
Gan, Gregory N. ;
Heron, Dwight E. ;
Selvaraj, Rai N. ;
Kim, Hayeon ;
Lalonde, Ron ;
Kelley, Joseph L. ;
Edwards, Robert P. .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 68 (01) :166-171
[3]  
Boehling NS, 2010, INT J RADIAT ONCOL, V82, P643, DOI DOI 10.1016/J.IJROBP.2010.11.02721277111
[4]   Adjuvant concurrent chemoradiotherapy with intensity-modulated pelvic radiotherapy after surgery for high-risk, early stage cervical cancer patients [J].
Chen, Miao-Fen ;
Tseng, Chih-Jen ;
Tseng, Ching-Cheng ;
Yu, Chun-Yen ;
Wu, Chun-Te ;
Chen, Wen-Cheng .
CANCER JOURNAL, 2008, 14 (03) :200-206
[5]   Predictors of Grade 3 or Higher Late Bowel Toxicity in Patients Undergoing Pelvic Radiation for Cervical Cancer: Results From a Prospective Study [J].
Chopra, Supriya ;
Dora, Tapas ;
Chinnachamy, Anand N. ;
Thomas, Biji ;
Kannan, Sadhna ;
Engineer, Reena ;
Mahantshetty, Umesh ;
Phurailatpam, Reena ;
Paul, Siji N. ;
Shrivastava, Shyam Kishore .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 88 (03) :630-635
[6]   Intensity Modulated Proton Beam Radiation for Brachytherapy in Patients With Cervical Carcinoma [J].
Clivio, Alessandro ;
Kluge, Anne ;
Cozzi, Luca ;
Koehler, Christhardt ;
Neumann, Oliver ;
Vanetti, Eugenio ;
Wlodarczyk, Waldemar ;
Marnitz, Simone .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (05) :897-903
[7]   RADIATION-ASSOCIATED KIDNEY INJURY [J].
Dawson, Laura A. ;
Kavanagh, Brian D. ;
Paulino, Arnold C. ;
Das, Shiva K. ;
Miften, Moyed ;
Li, X. Allen ;
Pan, Charlie ;
Ten Haken, Randall K. ;
Schultheiss, Timothy E. .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 76 (03) :S108-S115
[8]   Conformity index:: A review [J].
Feuvret, L ;
Noël, G ;
Mazeron, JJ ;
Bey, P .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 64 (02) :333-342
[9]   Assessment of Improved Organ at Risk Sparing for Advanced Cervix Carcinoma Utilizing Precision Radiotherapy Techniques [J].
Georg, Dietmar ;
Georg, Petra ;
Hillbrand, Martin ;
Poetter, Richard ;
Mock, Ulrike .
STRAHLENTHERAPIE UND ONKOLOGIE, 2008, 184 (11) :586-591
[10]  
Georg P, 2010, INT J RADIAT ONCOL, V82, P653